CGEM vs MTB · $830.3M cap vs P/E 12, $30.99B cap
Cullinan Oncology LLC (CGEM) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
MTB does not have a complete income-statement cache yet.
CGEM currently screens at market cap $830.3M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the CGEM and MTB stock pages for the full models.
Not investment advice.